Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-13

Clinical Trial Update: Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) [Phase 2]

View source ↗

Summary

Phase 2 study update evaluating a diet-based treatment for Glucose Transporter Type 1 Deficiency Syndrome (GLUT1DS), with epilepsy as a co-occurring condition; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: GLUT1DS1, Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2025-04-13